Literature DB >> 23794468

Zero reference level for right heart catheterisation.

Gabor Kovacs1, Alexander Avian, Andrea Olschewski, Horst Olschewski.   

Abstract

Although in the pulmonary circulation small pressure differences may alter the categorisation of patients, there is no consensus on a standard zero reference level (ZRL). In the supine position, ZRL is mostly set at "5 cm below anterior thorax surface", "1/3 thoracic diameter below anterior thorax surface", "mid-thoracic level" or "10 cm above table level". We retrospectively assessed the distance of these four ZRLs from computed tomography-derived right and left atrial centre levels and from one another in patients undergoing right heart catheterisation and calculated the respective differences in pressure readings. We included 196 consecutive patients. The ZRL at "1/3 thoracic diameter" was most often (98.5%) level with the right atrium, and the ZRL at "mid-thoracic level" was level with the left atrium (97.4%), revealing a median (range) pressure difference of -0.3 (-3.0-1.3) and 0.2 (-2.0-1.3) mmHg from the right and left atrial centre level, respectively. The largest differences (8.0 (2.0-15.4) mmHg) were found between the ZRLs "5 cm below anterior thorax surface" and "10 cm above table level". Accordingly, 59% versus 80% of patients would be classified with pulmonary hypertension and 7% versus 38% with elevated left heart pressures. The choice of ZRL strongly influences pulmonary pressure readings and pulmonary hypertension classification. 1/3 thoracic diameter mostly represents the right atrium while the left atrium is best represented by the mid-thoracic level.

Entities:  

Mesh:

Year:  2013        PMID: 23794468     DOI: 10.1183/09031936.00050713

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  34 in total

Review 1.  Classification and diagnosis of pulmonary hypertension.

Authors:  Hector R Cajigas; Rana Awdish
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 2.  Pulmonary hypertension 2015: current definitions, terminology, and novel treatment options.

Authors:  Stephan Rosenkranz
Journal:  Clin Res Cardiol       Date:  2014-12-06       Impact factor: 5.460

3.  Reducing radiation dose in the diagnosis of pulmonary embolism using adaptive statistical iterative reconstruction and lower tube potential in computed tomography.

Authors:  David Kaul; Ulrich Grupp; Johannes Kahn; Pirus Ghadjar; Edzard Wiener; Bernd Hamm; Florian Streitparth
Journal:  Eur Radiol       Date:  2014-07-10       Impact factor: 5.315

4.  Reliance on end-expiratory wedge pressure leads to misclassification of pulmonary hypertension.

Authors:  Barbara L LeVarge; Eugene Pomerantsev; Richard N Channick
Journal:  Eur Respir J       Date:  2014-06-12       Impact factor: 16.671

5.  Evaluation of external reference levels for central venous pressure measurements of severely obese patients in the supine position.

Authors:  Kazuyuki Mizunoya; Hitoshi Saito; Yuji Morimoto
Journal:  J Anesth       Date:  2018-05-28       Impact factor: 2.078

6.  Central cardiac limit to aerobic capacity in patients with exertional pulmonary venous hypertension: implications for heart failure with preserved ejection fraction.

Authors:  Mário Santos; Alexander R Opotowsky; Amil M Shah; Julie Tracy; Aaron B Waxman; David M Systrom
Journal:  Circ Heart Fail       Date:  2014-12-30       Impact factor: 8.790

7.  Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension.

Authors:  Stéphanie Saxer; Mona Lichtblau; Charlotte Berlier; Elisabeth D Hasler; Esther I Schwarz; Silvia Ulrich
Journal:  Lung       Date:  2019-07-01       Impact factor: 2.584

8.  Optimal Transducer Level for Atrial and Pulmonary Arterial Pressure Measurement in Patients with Functional Single Ventricle.

Authors:  Yong-Hee Park; Da-Hye Yoo; Eun-Hee Kim; In-Kyung Song; Ji-Hyun Lee; Hee-Soo Kim; Woong-Han Kim; Jin-Tae Kim
Journal:  Pediatr Cardiol       Date:  2016-10-01       Impact factor: 1.655

Review 9.  Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection-Focus on Group II Pulmonary Hypertension.

Authors:  Bhavadharini Ramu; Brian A Houston; Ryan J Tedford
Journal:  Curr Heart Fail Rep       Date:  2018-04

10.  Comprehensive Diagnostic Evaluation of Cardiovascular Physiology in Patients With Pulmonary Vascular Disease: Insights From the PVDOMICS Program.

Authors:  W H Wilson Tang; Jennifer D Wilcox; Miriam S Jacob; Erika B Rosenzweig; Barry A Borlaug; Robert P Frantz; Paul M Hassoun; Anna R Hemnes; Nicholas S Hill; Evelyn M Horn; Harsimran S Singh; David M Systrom; Ryan J Tedford; Rebecca R Vanderpool; Aaron B Waxman; Lei Xiao; Jane A Leopold; Franz P Rischard
Journal:  Circ Heart Fail       Date:  2020-02-24       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.